Complement component C5 deficiency reduces edema formation in murine ligation-induced acute pancreatitis

Journal of Surgical Research

Volumn 67, Issue 1, 1997, Pages 40-45

  Merriam, Louis T ^a   Webster, Cecile ^a   Joehl, Raymond J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A [DEARGININE];

ACUTE PANCREATITIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CAPILLARY PERMEABILITY; COMPLEMENT ACTIVATION; COMPLEMENT DEFICIENCY; CONTROLLED STUDY; EDEMA; HYPERAMYLASEMIA; INTRAHEPATIC BILE DUCT; MALE; MOUSE; NONHUMAN; PANCREAS DUCT LIGATION; PRIORITY JOURNAL;

EID: 0030898910     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.4916     Document Type: Article

References (33)

1. 1. Bult, H., and Herman, A. G. Inflammatory mediators released by complement-derived peptides. Agents Actions 13: 405, 1983.
2. 2. Rother, K., Rother, U., and Hansch, G. The role of complement in inflammation. Pathol. Res. Pract. 80: 117, 1985.
3. 3. Rother, K., and Till, G. O. The Complement System. Berlin/New York: Springer-Verlag, 1988.
4. 4. Perez, H. D. Biologically active complement (C5)-derived peptides and their relevance to disease. Crit. Rev. Oncol. Hematol. 1: 199, 1984.
5. 5. Williams, T. J., and Jose, P. J. Mediation of increased vascular permeability after complement activation. Histamine-independent action of rabbit C5a. J. Exp. Med. 153: 136, 1981.
6. 6. Teixeira, M. M., Reynia, S., Robinson, M., Shock, A., Williams, T. J., Williams, F. M., Rossi, A. G., and Hellewell, P. G. Role of CD18 in the accumulation of eosinophils and neutrophils and local oedema formation in inflammatory reactions in guinea-pig skin. Br. J. Pharmacol. 111: 811, 1994.
7. +--initiated activation of cellular protein kinases. J. Biol. Chem. 262: 13674, 1987.
8. 8. Weidmer, T., Esmon, C. T., and Sims, P. J. On the mechanism by which complement proteins C5b-9 increase platelet prothrombinase activity. J. Biol. Chem. 261: 14587, 1986.
9. 9. Horn, J. K., Ranson, J. H. C., Goldstein, I. M., Weissler, J., Curotola, D., Taylor, R., and Perez, D. Evidence of complement catabolism in experimental acute pancreatitis. Am. J. Pathol. 101: 205, 1980.
10. 10. Bengtsson, A., Bengtson, J. P., Rydenhag, A., Roxvall, L., and Heideman, M. Accumulation of anaphylatoxins and terminal complement complexes in inflammatory fluids. J. Int. Med. 228: 173, 1990.
11. 11. Seelig, R., Ehemann, V., Tschahargane, C., and Seelig, H. P. The serum complement system - A mediator of acute pancreatitis. Virch. Arch. A Pathol. Anat. Histol. 365: 193, 1975.
12. 12. Roxvall, L. I., Bengtson, L. A., and Heideman, M. Il. Anaphylatoxins and terminal complement complexes in pancreatitis. Evidence of complement activation in plasma and ascites fluid of patients with acute pancreatitis. Arch. Surg. 125: 918, 1990.
13. 13. Roxvall, L., Bengtson, A., and Heideman, M. Anaphylatoxin generation in acute pancreatitis. J. Surg. Res. 47: 138, 1989.
14. 14. Mulligan, M. S., Yeh, G. C., Rudolph, A. R., and Ward, P. A. Protective effects of soluble CR1 in complement-and neutrophil-mediated tissue injury. J. Immunol. 148: 1479, 1991.
15. 15. Guice, K. S., Oldham, K. T., Caty, M. G., Johnson, K. J., and Ward, P. A. Neutrophil-dependent, oxygen-radical-mediated lung injury associated with acute pancreatitis. Ann. Surg. 210: 740, 1989.
16. 16. D'eustachio, P., Kristensen, T., Wetsel, R. A., Riblet, R., Taylor, B. A., and Tack, B. F. Chromosomal location of the genes encoding complement components C5 and factor H in the mouse. J. Immunol. 137: 3990, 1986.
17. 17. Ooi, Y. M., and Colten, H. R. Genetic defect in secretion of complement C5 in mice. Nature 282: 207, 1979.
18. 18. Merriam, L. T., Wilcockson, D., Samuel, I., and Joehl, R. J. Ligation-induced acute pancreatitis increases pancreatic and circulating trypsinogen activation peptides. J. Surg. Res. 60: 417, 1996.
19. 19. Ohshio, G., Saluja, A., and Steer, M. L. Effects of short-term pancreatic duct obstruction in rats. Gastroenterology 100: 196, 1991.
20. 20. Buchler, M. Objectification of the severity of acute pancreatitis. Hepato-gastroenterology 38: 101, 1991.
21. 21. Griesbacher, T., Tiran, B., and Lembeck, F. Pathological events in experimental acute pancreatitis prevented by the bradykinin antagonist, Hoe 140. Br. J. Pharmacol. 108: 405, 1993.
22. 22. Griesbacher, T., and Lembeck, F. Effects of the bradykinin antagonist, Hoe 140, in experimental acute pancreatitis. Br. J. Pharmacol. 107: 356, 1992.
23. 23. Norman, J. G., Franz, M. G., Fink, G. S., Messina, J., Fabri, P. J., Gower, W. R., and Carey, L. C. Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Ann. Surg. 221: 625, 1995.
24. 24. Norman, J., Franz, M., Messina, J., Riker, A., Fabri, P. J., Rosemurgy, A. S., and Gower, W. R. Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 117: 648, 1995.
25. 25. Guice, K. S., Oldham, K. T., Remick, D. G., Kunkel, S. L., and Ward, P. A. Anti-tumor necrosis factor antibody augments edema formation in caerulein-induced acute pancreatitis. J. Surg. Res. 51: 495, 1991.
26. 26. Merriam, L. T., Wilcockson, D. P., and Joehl, R. J. Ligation-induced acute pancreatitis is associated with early activation of complement. Gastroenterology 108: A1233, 1995. [Abstract]
27. 27. Issekutz, T. B. In vivo blood monocyte migration to acute inflammatory reactions, IL-1alpha, TNF-alpha, INF-gamma, and C5a utilizes LFA-1, MAC-1 and VLA-4. The relative importance of each integrin. J. Immunol. 154: 6533, 1995.
28. 28. Fernandez, H. N., Henson, P. M., Otani, A., and Hugli, T. E. Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under simulated in vivo conditions. J. Immunol. 120: 109, 1978.
29. 29. Williamson, L. M., Sheppard, K., Davies, J. M., and Fletcher, J. Neutrophils are involved in the increased vascular permeability produced by activated complement in man. Br. J. Haematol. 64: 375, 1986.
30. 30. Williams, T. J., and Peck, M. J. Role of prostaglandin-mediated vasodilatation in inflammation. Nature 270: 530, 1977.
31. 31. Williams, T. J. Prostaglandin E2, prostaglandin I2 and the vascular changes of inflammation. Br. J. Pharmacol. 65: 517, 1979.
32. 32. Wedmore, C. V., and Williams, T. J. Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature 289: 646, 1981.
33. 33. Sedgwick, A. D., Moore, A. R., Al-Duaij, A., and Willoughby, D. A. Studies into the association between leucocyte accumulation and oedema formation. Agents Actions 17: 209, 1985.